A Type III CRISPR Ancillary Ribonuclease Degrades Its Cyclic Oligoadenylate Activator
A Type III CRISPR Ancillary Ribonuclease Degrades Its Cyclic Oligoadenylate Activator
复制标题
DOI:
10.1101/582114
复制
发表时间:
2019-03
影响因子:
5.6
通讯作者:
Januka S. Athukoralage;S. Graham;Sabine Grueschow;Christophe Rouillon;M. F. White
中科院分区:
文献类型:
--
作者:
Januka S. Athukoralage;S. Graham;Sabine Grueschow;Christophe Rouillon;M. F. White
Cyclic oligoadenylate (cOA) secondary messengers are generated by type III CRISPR systems in response to viral infection. cOA allosterically activates the CRISPR ancillary ribonucleases Csx1/Csm6, which degrade RNA non-specifically using a HEPN (Higher Eukaryotes and Prokaryotes, Nucleotide binding) active site. This provides effective immunity, but can also lead to growth arrest in infected cells, necessitating a means to deactivate the ribonuclease once viral infection has been cleared. In the crenarchaea, dedicated ring nucleases degrade cA4 (cOA consisting of 4 AMP units), but the equivalent enzyme has not been identified in bacteria. We demonstrate that, in Thermus thermophilus HB8, the uncharacterised protein TTHB144 is a cA4-activated HEPN ribonuclease that also degrades its activator. TTHB144 binds and degrades cA4 at an N-terminal CARF (CRISPR Associated Rossman Fold) domain. The two activities can be separated by site-directed mutagenesis. TTHB144 is thus the first example of a self-limiting CRISPR ribonuclease. Graphical abstract